BioRem Ownership
| BRM Stock | CAD 2.40 0.02 0.83% |
Shares in Circulation | First Issued 2004-09-30 | Previous Quarter 15.7 M | Current Value 18.5 M | Avarage Shares Outstanding 21.5 M | Quarterly Volatility 12.2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
BioRem |
BioRem Stock Ownership Analysis
The book value of the company was currently reported as 0.43. The company had not issued any dividends in recent years. BioRem Inc had 1:4 split on the 21st of January 2005. BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds , and hazardous air pollutants in Canada, the United States, China, and internationally. In addition, it offers biological processes and testing services media sampling and analysis system review and inspections and media replacements and spare parts. BIOREM INC operates under Pollution Treatment Controls classification in Canada and is traded on TSX Venture Exchange. For more info on BioRem Inc please contact PEng MBA at 519 767 9100 or go to https://www.biorem.biz.BioRem Outstanding Bonds
BioRem issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioRem Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioRem bonds can be classified according to their maturity, which is the date when BioRem Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.